The reverse merger into crypto mining with heavy dilution suggests existing shares will be significantly revalued. Monitor stockholder approval and Nasdaq listing conditions. The milestone earnout shares add further overhang. Traders should expect high volatility and potential downside for legacy SHPH holders.
Price Chart
Executive Summary
Shuttle Pharmaceuticals entered into a merger agreement with United Dogecoin Inc., a dogecoin mining company, and concurrently raised $11M through a PIPE offering of Series B-2 Convertible Preferred Stock and warrants. The transaction represents a transformative shift from pharmaceuticals to crypto mining, but existing SHPH shareholders face massive dilution as the merger consideration grants United Dogecoin holders 75.65% of the pro forma equity on an as-converted basis.
Key Financial Metrics
Key Facts
- Entry into Merger Agreement with United Dogecoin Inc., a dogecoin mining company
- PIPE offering of $11M in Series B-2 Convertible Preferred Stock plus warrants for 100% warrant coverage at $1.03 per share
- Merger consideration: United Dogecoin stockholders receive 75.65% of the combined entity on an as-converted basis, excluding PIPE shares
- Up to 32.6M additional milestone shares issuable for achieving mining rig purchase, uptime, and power cost targets
- Existing SHPH market cap is only $6M; the transaction is massively dilutive to current shareholders
- No revenue or financial figures for either company disclosed in the filing
Financial Impact
PIPE gross proceeds of $11,000,000, but existing shareholders diluted to approximately 24.35% on an as-converted basis
Risk Factors
- Massive dilution to existing shareholders: legacy stake reduced to ~24% on pro forma basis
- Stockholder approval and Nasdaq listing requirements may not be met
- Milestone conditions for earnout shares are speculative and may not be achieved
- Integration and execution risk in transitioning from pharma to crypto mining
- No financial statements for United Dogecoin provided; valuation opaque
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 2 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| 8-K Filing (Primary) | 0001493152-26-020830 |
| Exhibit: ex2-1.htm | 0001493152-26-020830 |
Track record builds as more directional reports settle.
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Sep 1, 2026 4w ago | 8-K | $3.49 $4.04 | ▲ +15.76% | ▲ +16.09% | $4.17 (+19.48%) |
Jul 13, 2026 11w ago | 3 | $2.96 $4.07 | ▲ +37.50% | ▲ +34.32% | $4.17 (+40.88%) |
Jul 1, 2026 13w ago | 3 | $3.58 $3.09 | ▼ −13.69% | ▼ −13.27% | $4.17 (+16.48%) |
Jun 11, 2026 16w ago | 8-K | $3.91 $2.92 | ▼ −25.32% | ▼ −27.10% | $4.17 (+6.65%) |
May 7, 2026 21w ago | 8-K | $6.89 $4.84 | ▲ +29.75% | ▲ +29.97% | $4.17 (+39.48%) |
May 1, 2026 22w ago | 8-K | $6.92 $5.33 | ▲ +22.98% | ▲ +28.23% | $4.17 (+39.74%) |
Mar 10, 2026 29w ago | 8-K | $0.9010 $0.7250 | ▼ −19.53% | ▼ −20.06% | $4.17 (+362.82%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access